Dr. Peng Zhang, MD

Dr. Zhang practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Zhang's NPI, 1063829646, was assigned on July 16, 2014. Dr. Zhang holds Ohio license 57029102.

Dr. Zhang's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Zhang's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Zhang is also affiliated with Hillcrest Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Zhang to 2 more clinical labs, each named with a free account. Dr. Zhang's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhang practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Zhang's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Zhang is licensed in Ohio.

CMS data shows 343 Medicare services from Dr. Zhang across 3 procedure codes in 2024, for 129 Medicare patients. Medicare paid $34,433 for them.

CMS counts 129 Medicare patients who saw Dr. Zhang in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhang's median patient age at 62, with 65% women.

In 2024, Dr. Zhang wrote 958 Medicare Part D claims for 141 patients. 31% of them were for generic drugs. CMS names the drug for 857 of them, across 18 drugs with 11 or more claims each, at $393,984 in total drug cost. In 2023, CMS named 567 claims across 11 drugs.

Dr. Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhang as offering telehealth.

Dmand AI links 15 papers to Dr. Zhang, published from 2014 to 2021. 2017 was the busiest year, with 3. The most frequent topics are Drug Liberation, Magnesium and Porosity. Dr. Zhang has published most often in Int J Pharm. Dr. Zhang's most frequent co-authors are Rashmi N. Aurora, MD, Aesha M. Jobanputra, MD and Matthew T. Scharf, MD.

CMS Open Payments shows 3 general payments to Dr. Zhang from 3 drug and device companies in 2022. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $29.